Targeting Cellular Signalling Pathways in Lung Diseases (Paperback)

Chapter 1. Introduction to Lung Diseases.- Chapter 2. Targeting molecular and cellular mechanisms in asthma.-Chapter 3. Various cellular and molecular axis involved in the pathogenesis of asthma.- Chapter 4. Targeting molecular and cellular mechanisms in steroid resistant asthma.- Chapter 5. Targeting molecular and cellular mechanisms in chronic obstructive pulmonary disease.- Chapter 6. Probing the cellular and molecular mechanisms underlying in the pathogenesis of Chronic Obstructive Pulmonary Disease (COPD).- Chapter 7. Chronic obstructive pulmonary disease: Molecular basis of pathogenesis and targeted therapeutic approaches.- Chapter 8. Exploring the ‘dormancy-activation switch’ in the tumour microenvironment for metastatic lung cancer: The possible role of microRNA.- Chapter 9. Therapeutic strategies targeting signalling pathways in lung cancer.- Chapter 10. Modulation of signalling pathways by immunotherapeutics in lung cancer.- Chapter 11. Underpinning the Cellular and Molecular Mechanisms with Nanotheronstics for Lung Cancer.- Chapter 12. Targeting molecular and cellular mechanisms in Idiopathic Pulmonary Fibrosis.-Chapter 13. A refined approach to target the molecular and cellular mechanisms in pulmonary fibrosis.-Chapter 14. Targeting molecular and cellular mechanisms in tuberculosis.- Chapter 15. Cellular and Molecular Mechanisms of Repurposed antidiabetic drug as adjunctive treatment for tuberculosis.- Chapter 16. Targeting host and bacterial signaling pathways in tuberculosis: An effective strategy for the development of novel anti-tubercular therapies.- Chapter 17. Targeting molecular and cellular mechanisms in pulmonary hypertension.- Chapter 18. Targeting molecular and cellular mechanisms in pulmonary arterial hypertension.- Chapter 19. Potential cellular targets associated with the signaling and therapeutics of the pulmonary hypertension.- Chapter 20. Targeting molecular and cellular mechanisms in influenza A virus infections.- Chapter 21. Understanding the Biology of Non-typeable Haemophilus influenzae in Chronic Obstructive Pulmonary Disease through the Lens of Genomics.- Chapter 22. Targeting molecular and cellular mechanisms in rhinovirus infection.- Chapter 23. Targeting molecular and cellular mechanisms in respiratory syncytial virus (RSV) infection.- Chapter 24. Targeting molecular and cellular mechanisms SARS-CoV2 novel corona (COVID-19) virus infection.- Chapter 25. Underpinning the rudimentary mechanisms involved in the pathogenesis of SARS-CoV2 (COVID-19) in human lung cells.- Chapter 26. Targeting molecular and cellular mechanisms in SARS-CoV2 novel corona (COVID-19) virus infection.- Chapter 27. Special features of human lung ACE2 sensitivity to SARS CoV-2 spike glycoprotein.- Chapter 28. Implications of Phosphoinositide 3-kinase (PI3K) Signalling in cellular and molecular mechanisms of respiratory diseases.- Chapter 29. The role of the cholinergic system in lung diseases.- Chapter 30. The Nrf2-Keap1 signaling pathway in lung cancer.- Chapter 31. Role of Toll like receptor (LTR) in molecular and cellular mechanism of respiratory diseases.- Chapter 32. Biomarkers of Oxidative Stress.- Chapter 33. Targeting chronic lung diseases using advanced drug delivery systems.- Chapter 34. Plant based chemical moieties targeting cellular signalling pathways in chronic lung diseases.- Chapter 35. Role of phytoconstituents in targeting cytokines for managing pathophysiology of lung diseases.- Chapter 36. Targeting Cellular Signaling Pathways in Lung Cancer and Role of Phytochemicals as Novel Therapeutic Approach.- Chapter 37. Natural compounds targeting major signalling pathways in lung cancer.- Chapter 38. Drug delivery in respiratory diseases: Current opportunities,  Molecular and cellular mechanism, and Future challenges.- Chapter 39. Future prospects and challenges in targeting cellular and molecular mechanisms in respiratory diseases.